Robin Mukherjee

Robin Mukherjee is a Director at Actelion with extensive experience in clinical development across major pharmaceutical companies including Pfizer, BMS, and Merck. Holding a PhD in Biostatistics from the University of Florida, he specializes in leading clinical programs for conditions like asthma, COPD, and pulmonary hypertension.

While his public profile is focused on his professional accomplishments, he maintains a strong connection to his alma mater, the University of Florida, which is a noted interest. This suggests a deep appreciation for his academic and scientific foundations.

He has co-authored multiple clinical research publications, including specialized studies on treatments for systemic sclerosis-associated digital ulcers.